Life Science Investing Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
Life Science Investing Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
Life Science Investing Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
Life Science Investing Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Life Science Investing Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference
Life Science Investing Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
Skyharbour Announces Additional Uranium Property Staking Increasing Total Portfolio to Over 662,000 Hectares in the Athabasca Basin, Saskatchewan
Homerun Resources Inc. Announces Full Mining Permit and Finalization of the Definitive Lease Agreement With CBPM
